Skip to content

Medtronic MDT Medical Surgical — Reportable segment operating profit

Other segment segments

Cardiovascular
$1.07B+11.8%
Neuroscience
$879M+2.4%
Diabetes
$57M+14.0%
Other operating segment
-$1M-108%

Similar metrics at other companies

Boston Scientific logo
BSXMedSurg — Segment operating income, percentage of net sale
31.3%-2.0pp
Boston Scientific logo
BSXMedSurg — Operating Income (Loss), Adjusted
$533M-0.6%
ROP
ROPMedical And Scientific Imaging — Segment Operating Profit
$121.32M+6.2%
Becton, Dickinson and Company logo
BDXMedical — Segment Operating Income as a Percent of Revenues
9%+0.1pp
STERIS logo
STEOperatingSegmentAllExceptCorpandOther — Operating Income (Loss)
$229.63M+9.9%
Boston Scientific logo
BSXMedSurg — Net sales of reportable segments
$1.7B+5.7%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$101.86B-3.8%
Enterprise value$129.12B-3.2%
P/E21.2×-1.5×
P/S2.8×-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's medical surgical — reportable segment operating profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's medical surgical — reportable segment operating profit?
Medtronic (MDT) reported medical surgical — reportable segment operating profit of $605M in Q1 2026.
How has Medtronic's medical surgical — reportable segment operating profit changed year-over-year?
Medtronic's medical surgical — reportable segment operating profit increased by 5.2% year-over-year, from $575M to $605M.
What is the long-term trend for Medtronic's medical surgical — reportable segment operating profit?
Over 4 years (2022 to 2026), Medtronic's medical surgical — reportable segment operating profit has grown at a -12.9% compound annual growth rate (CAGR), from $3.7B to $2.13B.
What does medical surgical — reportable segment operating profit mean?
The profit earned by the Medical Surgical segment after accounting for all operating expenses.
How do you interpret medical surgical — reportable segment operating profit?
Higher operating profit indicates strong operational leverage and effective cost management within the segment.
How does medical surgical — reportable segment operating profit compare across companies?
Standard segment operating income reported by peers in the medical technology industry.